Skip to Content
Merck
  • A novel synthetic approach of cerium oxide nanoparticles with improved biomedical activity.

A novel synthetic approach of cerium oxide nanoparticles with improved biomedical activity.

Scientific reports (2017-07-07)
Fanny Caputo, Marta Mameli, Andrzej Sienkiewicz, Silvia Licoccia, Francesco Stellacci, Lina Ghibelli, Enrico Traversa
ABSTRACT

Cerium oxide nanoparticles (CNPs) are novel synthetic antioxidant agents proposed for treating oxidative stress-related diseases. The synthesis of high-quality CNPs for biomedical applications remains a challenging task. A major concern for a safe use of CNPs as pharmacological agents is their tendency to agglomerate. Herein we present a simple direct precipitation approach, exploiting ethylene glycol as synthesis co-factor, to synthesize at room temperature nanocrystalline sub-10 nm CNPs, followed by a surface silanization approach to improve nanoparticle dispersibility in biological fluids. CNPs were characterized using transmission electron microscopy (TEM) observations, X-ray diffraction (XRD) analysis, thermogravimetric analysis (TGA), Fourier-transform infrared (FT-IR) spectroscopy, proton nuclear magnetic resonance (

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Natriuretic Peptide, C-Type, ≥95% (HPLC)